The value of tumour markers in lung cancer

British Journal of Cancer

Volumn 58, Issue 6, 1988, Pages 797-804

  Gomm, S A ^a   Keevil, B G ^a   Thatcher, N ^a   Hasleton, P S ^a   Swindell, R S ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE ISOMERASE; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

AGE; ANTIGEN ANTIBODY COMPLEX; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ALKALINE PHOSPHATASE; ANTIGEN-ANTIBODY COMPLEX; ASPARTATE AMINOTRANSFERASES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0024272615     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.312     Document Type: Article

References (39)

1. AKOUN, G.M., SCARNA, H.M., MILLERON, B.J., BENICHOU, M.P. & HERMON, D.P. (1985). A marker for disease extent and response to therapy for small cell lung cancer. Chest, 87, 39.
2. ARIYOSHI, Y., KATO, K., ISHIGURO, Y., OTA, K., SATO, T. & SUCHI, T. (1983). Evaluation of serum neuron specific enolase as a tumour marker for carcinoma lung. Gann., 74, 219.
3. BAYLIN, S.B., GOODMAN, G. & SHAPER, J.H. (1982). Analysis of cell surface proteins as a means to study neuroendocrine differentiation in the spectrum of human lung cancers. In Systemic Role of Regulatory Peptides, Bloom et al. (eds) p. 307. Verlag: Stuttgart.
4. BODANSKY, O. (1954). Serum phosphohexose isomerase in cancer. Cancer, 7, 1200.
5. CARNEY, D.N., IHDE, D.C. & COHEN, M.H. & 4 others (1982). Serum neuron-specific enolase: A marker for disease extent and response to therapy of small cell lung cancer. Lancet, 1, 583.
6. CARNEY, D.N. (1987). Clinical relevance of lung cancer biology. Br. J. Cancer, 56, 884.
7. CERNY, T., BLAIR, V., ANDERSON, H., BRAMWELL, V. & THATCHER, N. (1987). Pre-treatment prognostic factors and scoring systems in 407 small cell lung cancer patients. Int. J. Cancer, 39, 146.
8. COHEN, M.H., MAKUCH, R., JOHNSTON-EARLY, A. & 4 others (1981). Laboratory parameters or an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treatment Rep., 65, 187.
9. COOPER, E.H., MUER, M.F., PEAKE, M.D., JORGENSON, L. & HANSEN, H.H. (1987). Neuron-specific enolase, CEA and acute phase proteins in the monitoring of small cell lung cancer. Br. J. Cancer, 56, 890.
10. COX, D.R. (1972). Regression models and life tables. J. Statis. Soc. (A), 35, 185.
11. D'ERIL, G.M., PAVESI, F., LOTZNIKER, M. & MORATTI, R. (1986). More on phosphohexose isomerase as a tumour marker. Clin. Chem., 32, 1242.
12. DHILLON, A.P., RODE, J., DHILLON, D.P., MOSS, E., ON, R.J. & SPIRO, S.G. (1985). Neural markers in carcinoma of the lung. Br. J. Cancer, 51, 645.
13. ESSCHER, T., STEINHOLTZ, L., BERGH, J., NOU, E., NILSSON, K. & PAHLMAN, S. (1985). Neuron specific enolase: A useful diagnostic serum marker for small cell carcinoma of the lung. Thorax, 40, 85.
14. GAZDAR, A.F., CARNEY, D.N. & MINNA, J.D. (1983). The biology of non-small cell lung cancer. Semin. Oncol., 10, 3.
15. GROPP, C., HAVEMANN, K., SCHERFE, T. & AX, W. (1980). Incidence of circulating immune complex in patients with lung cancer and their effect on antibody dependent cytotoxicity. Oncology, 37, 71.
16. HAVEMANN, K., HOLLE, R. & GROPP, C. (1985). Prospective multicentre study of hormone markers in small cell lung cancer. In Peptide Hormones in Lung Cancer, Havemann et al. (eds). Springer-Verlag: Berlin.
17. HEIMER, R. & KLEVI, G. (1976). Circulating immune complexes in sera of patients with Burkitt's lymphoma and nasopharyngeal carcinoma. Int. J. Cancer, 18, 310.
18. IHDE, D.C., MAKUCH, R.W., CARNEY, D.N. & 4 others (1981). Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am. Rev. Resp. Dis., 123, 500.
19. JOHNSON, D.H., MARANGOS, P.J., FORBES, J.T. & 4 others (1984). Potential utility of serum neuron specific enolase levels in small cell carcinoma of the lung. Cancer Res., 44, 5409.
20. KAPLAN, E.L. & MEIER, P. (1958). Non-parametric estimation from incomplete observations. J. Am. Statist. Assoc., 53, 457.
21. KATO, K., ASAI, R., SHIMIZU, A., SUZUKI, F. & ARIYOSHI, Y. (1983). Immunoassay of three enolase isoenzymes in human serum and in blood cells. Clin. Chem. Acta., 127, 353.
22. KRAPF, F., RENGER, B., SCHEDEL, I., LEINDECKER, K., LEYSSENS, H. & DEIEHER, H. (1982). PEG-precipitation laser nephelometer technique for detection and characteristics of circulating immune complexes in human sera. J. Immunol. Meth., 54, 107.
23. LANZOTFRI, V.L., THOMAS, D.R., BOYLE, L.E., SMITH, T.L., GEHAN, E.A. & SAMUELS, M.L. (1977). Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria. Cancer, 39, 303.
24. LEVINSON, S.S., GOLDMAN, J.O. & FELDKAMP, C.S. (1984). Anti- IgG binding test to assay circulating IgG-containing immune complexes from polyethylene glycol precipitates. Clin. Chem., 90, 1502.
25. MCDOWELL, E.M. & TRUMP, B.F. (1981). Pulmonary small cell carcinoma showing tripartate differentiation in individual cells. Hum. Pathol., 12, 286.
26. NEVILLE, A.M. & COOPER, E.H. (1976). Biochemical monitoring of cancer. A review. Ann. Clin. Biochem., 13, 283.
27. PAHLMAN, S., ESSCHER, T., BERGH, J., STINHOLTZ, L., NOU, E. & NILLSON, K. (1984). Neuron specific enolase as a marker for neuroblastoma and small cell carcinoma of the lung. Tumour Biology, 5, 119.
28. PETO, R., PIKE, M.C., ARMITAGE, P. & 7 others (1977). Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35, 1.
29. ROWAN, R.M. (1978). The assay of phosphoglucose isomerase in human serum. Medical Lab. Sci., 35, 155.
30. SCHWARTZ, M.K., DNISTRIAN, A.M., STANKIEVIC, R., MINDICINO, H. & SCHWARTZ, D. (1985). Phosphohexose isomerase (PHI) as a marker in lung cancer. Clin. Chem., 31, 983.
31. SIDHU, G. S. (1980). The ultrastructure of malignant epithelial neoplasms of the lung. Path. Ann., 1, 235.
32. SOUHAMI, R.L., BRADBURY, I., GEDDES, D.M., SPIRO, S.G., HARPER, P.G. & TOBIAS, J.S. (1985). Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res., 45, 2878.
33. STANLEY, K.E. (1985). Prognostic factors in lung cancer. In Lung Cancer, Aisner, J. (ed), Churchill Livingstone. Contemp. Issues Clin. Oncol., 3, 41.
34. TAPIA, F.J., BARBOSA, A.J.A., MARANGOS, P.J. & 3 others (1981). Neuron specific enolase is produced by neuroendocrine tumours. Lancet, i, 808.
35. TESHIMA, H., WANEBO, H., PINSKY, C. & DAY, N.K. (1977). Circulating immune complexes detected by 1251-Clq deviation test in sera of cancer patients. J. Clin. Invest., 59, 1134.
36. THEOFILOPOULUS, N., WILSON, C.B. & MULLER-EKERHARD, H.J. (1976). Clq deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. J. Exp. Med., 142, 139.
37. WEST, M., SCHWARTZ, M.A., WALSH, W.S. & ZIMMERMAN, H.J. (1962). Serum enzymes in disease. Glycolytic and oxidative enzymes and transaminases in patients with cancer of the lung. Cancer, 15, 931.
38. WILLIS, R.A. (1948). Pathology of Tumours. Butterworth, London.
39. ZELEN, M. (1973). Keynote address on biostatistics. Cancer Chemotherap. Rep., 4, 31.